Literature DB >> 22566388

Indications and complications of transfusions in sickle cell disease.

Kim Smith-Whitley1, Alexis A Thompson.   

Abstract

Red cell transfusion remains an important part of the management of acute and chronic complications in SCD. The ongoing and emerging uses of transfusions in SCD may have significant benefits; however, the potential complications of transfusions also deserve careful consideration. In this report we review current indications for transfusions, transfusion complications, modifications of transfusion practices to mitigate risk, and potential considerations to improve transfusion outcomes.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22566388     DOI: 10.1002/pbc.24179

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  14 in total

Review 1.  Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.

Authors:  Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Winfred C Wang
Journal:  Cochrane Database Syst Rev       Date:  2017-01-17

2.  Patrolling monocytes scavenge endothelial-adherent sickle RBCs: a novel mechanism of inhibition of vaso-occlusion in SCD.

Authors:  Yunfeng Liu; Hui Zhong; Weili Bao; Avital Mendelson; Xiuli An; Patricia Shi; Stella T Chou; Deepa Manwani; Karina Yazdanbakhsh
Journal:  Blood       Date:  2019-05-10       Impact factor: 22.113

3.  Current management of sickle cell anemia.

Authors:  Patrick T McGann; Alecia C Nero; Russell E Ware
Journal:  Cold Spring Harb Perspect Med       Date:  2013-08-01       Impact factor: 6.915

4.  Trends in blood transfusion among hospitalized children with sickle cell disease.

Authors:  Jean L Raphael; Suzette O Oyeku; Marc A Kowalkowski; Brigitta U Mueller; Angela M Ellison
Journal:  Pediatr Blood Cancer       Date:  2013-06-18       Impact factor: 3.167

5.  Severe hemolytic transfusion reaction due to anti-D in a D+ patient with sickle cell disease.

Authors:  Tina S Ipe; Jennifer J Wilkes; Helge D Hartung; Connie M Westhoff; Stella T Chou; David F Friedman
Journal:  J Pediatr Hematol Oncol       Date:  2015-03       Impact factor: 1.289

6.  Red cell transfusion and alloimmunization in sickle cell disease.

Authors:  Grace E Linder; Stella T Chou
Journal:  Haematologica       Date:  2021-07-01       Impact factor: 9.941

7.  Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.

Authors:  Lise J Estcourt; Ruchika Kohli; Sally Hopewell; Marialena Trivella; Winfred C Wang
Journal:  Cochrane Database Syst Rev       Date:  2020-07-27

8.  Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.

Authors:  Etheresia Pretorius; Janette Bester; Natasha Vermeulen; Boguslaw Lipinski; George S Gericke; Douglas B Kell
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

Review 9.  Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.

Authors:  Winfred C Wang; Kerry Dwan
Journal:  Cochrane Database Syst Rev       Date:  2013-11-14

Review 10.  Clinical pharmacology of deferasirox.

Authors:  Chiaki Tanaka
Journal:  Clin Pharmacokinet       Date:  2014-08       Impact factor: 5.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.